What happened
OpenAI, with CEO Sam Altman's direct involvement, is aggressively expanding into healthcare, securing eight major health systems, including Cedars-Sinai Medical Center and HCA Healthcare, as enterprise customers. The company has engaged hundreds of doctors to refine health answers for over 230 million global ChatGPT users and launched three new healthcare products in six months. These include a dedicated ChatGPT version for clinicians and a "ChatGPT Health" tab for secure medical record and wellness app integration, currently waitlist-only. OpenAI models also power other health companies' tools for clinical note generation and lab result interpretation.
Why it matters
Healthcare providers and patients face new AI integration points, shifting how medical information is accessed and processed. OpenAI's direct enterprise sales, coupled with consumer-facing tools like ChatGPT Health, introduce mechanisms for direct patient data connection and clinical workflow support. This push into a sector representing 18% of the U.S. economy follows OpenAI's reported $39 billion net loss in 2025 and missed revenue targets, underscoring the imperative for new, substantial revenue streams. Procurement teams and security architects must evaluate these offerings against existing infrastructure and data privacy regulations, particularly given hospitals' razor-thin margins.
